文献速递产科生殖医学

母亲多囊卵巢综合征与子代早期发育

Maternal polycystic ovarian syndrome and early offspring development.
PubMed 文献 · Hum Reprod · 2018-01-01

基于2008至2010年纽约州出生人群的前瞻性队列(Upstate KIDS研究),4453名母亲报告的子代至36月龄ASQ筛查显示,母亲PCOS诊断与子代精细运动失败风险升高相关(aOR=1.77;95%CI:1.09,2.89),女性单胎中更明显(aOR=2.23;1.16,4.29)。

要点

  • 母亲PCOS与子代ASQ精细运动失败风险升高相关(aOR=1.77;95%CI:1.09,2.89)。
  • 女性单胎中该关联更强(aOR=2.23;95%CI:1.16,4.29)。
  • PCOS母亲的双胎沟通(aOR=1.94;1.19,3.18)和个人-社会功能(aOR=1.76;1.12,2.77)失败风险升高。

核心结论

  • 母亲PCOS与子代ASQ筛查失败风险升高相关,作者认为若被证实,PCOS母亲子代可能存在发育迟缓风险升高。

研究设计与样本

  • Upstate KIDS研究为基于人群的前瞻性队列,纳入2008至2010年纽约州(不含纽约市)出生婴儿,随访至36月龄。
  • 共4453名母亲为5388名儿童完成一次以上发育筛查工具(35.5%为双胞胎),458名母亲(10.3%)报告医疗保健提供者诊断的PCOS及相关治疗。

主要发现

  • PCOS诊断与子代精细运动域失败风险升高相关(aOR=1.77;95%CI:1.09,2.89),主要来自女性单胎(aOR=2.23;95%CI:1.16,4.29)。
  • PCOS母亲的双胞胎沟通域(aOR=1.94;95%CI:1.19,3.18)和个人-社会功能域(aOR=1.76;95%CI:1.12,2.77)失败风险高于无PCOS母亲的双胞胎。
  • 报告未治疗PCOS的母亲子代ASQ失败关联(aOR=1.68;95%CI:0.95,2.75)强于报告接受PCOS治疗者(aOR=1.16;95%CI:0.79,1.73)。

关键数值与推荐

  • 采用广义线性混合模型估计PCOS诊断与ASQ失败之间的OR,校正母亲年龄、种族、BMI、教育、婚姻状况、吸烟、饮酒、糖尿病、保险和胎数。
  • ASQ在子代4、8、12、18、24、30和36月龄时评估精细运动、粗大运动、沟通、个人-社会功能和问题解决认知域。

临床怎么用

  • 作者认为若被证实,这些发现提示PCOS母亲子代可能存在发育迟缓风险升高。

局限性

  • 原文指出需进一步研究以医疗保健提供者验证的PCOS诊断来确认母亲PCOS在子代早期发育中的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is maternal polycystic ovarian syndrome (PCOS) associated with developmental delays in offspring? SUMMARY ANSWER: Offspring of mothers with PCOS were at higher risk of failure on the Ages and Stages Questionnaire (ASQ). WHAT IS KNOWN ALREADY: There is growing evidence that offspring of mothers with PCOS may be at higher risk for developmental disorders due to potential exposure to hyperandrogenism and insulin resistance. Few studies exist regarding maternal PCOS and early childhood development in the USA. STUDY DESIGN, SIZE, DURATION: The Upstate KIDS Study is a population-based prospective cohort study of infants born between 2008 and 2010 in New York State (excluding New York City), originally designed to study-and finding no impact of-infertility treatment exposure on child development. Children were followed up to 36 months of age. In all, 4453 mothers completed one or more developmental screening instruments for 5388 children (35.5% twins) up to 36 months of age. PARTICIPANTS/MATERIALS, SETTING, METHODS: In our study, 458 mothers (10.3%) reported a healthcare provider's diagnosis of PCOS, as well as the related treatment received, on the baseline study questionnaire. Parents completed the ASQ on their child's development at 4, 8, 12, 18, 24, 30 and 36 months of age to assess fine motor, gross motor, communication, personal-social functioning and problem-solving cognitive domains. We used generalized linear mixed models to estimate odds ratios (OR) between PCOS diagnosis and failures in the ASQ adjusted for maternal age, race, BMI, education, marital status, smoking, alcohol consumption, diabetes, insurance and plurality. MAIN RESULTS AND THE ROLE OF CHANCE: Diagnosis of PCOS was associated with increased risk of the offspring failing the fine motor domain (adjusted odds ratio (aOR) = 1.77; 95% CI: 1.09, 2.89), largely driven by higher risk in female singletons (aOR = 2.23; 1.16, 4.29). Twins of mothers with PCOS had higher risk of failing the communication (aOR = 1.94; 1.19, 3.18) and personal-social functioning (aOR = 1.76; 1.12, 2.77) domains compared to twins born to mothers without PCOS. Compared to offspring of women without PCOS, offspring of women who reported receiving no treatment for their PCOS had a stronger association with failing the ASQ (aOR = 1.68; 0.95, 2.75) than the association among offspring of women who reported PCOS treatment (aOR = 1.16; 0.79, 1.73). LIMITATIONS, REASONS FOR CAUTION: Further study is needed to confirm the role of maternal PCOS in early offspring development with provider-validated diagnosis of PCOS. WIDER IMPLICATIONS OF THE FINDINGS: If confirmed, these findings suggest that offspring of women with PCOS may be at increased risk for developmental delay. STUDY FUNDING/COMPETING INTEREST(S): Supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD; contracts HHSN275201200005C, #HHSN267200700019C). Authors have no competing interests to declare. TRIAL REGISTRATION NUMBER: Not applicable.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Bell GA, Sundaram R, Mumford SL, et al. Maternal polycystic ovarian syndrome and early offspring development. Hum Reprod. 2018. PMID: 29668891. doi:10.1093/humrep/dey087

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。